Medpace Holdings, Inc. Advertising Expense
Medpace Holdings, Inc. (MEDP) reported Advertising Expense of $1.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AdvertisingExpense · last filed 2026-02-10
- Medpace Holdings, Inc. advertising expense for fiscal 2025 was $1.50M, a 0.00% change from fiscal 2024.
- Medpace Holdings, Inc. advertising expense for fiscal 2024 was $1.50M, a 0.00% change from fiscal 2023.
- Medpace Holdings, Inc. advertising expense for fiscal 2023 was $1.50M, a 15.38% increase from fiscal 2022.
- Medpace Holdings, Inc. advertising expense for fiscal 2022 was $1.30M.
| Period end | Advertising Expense 12 month |
|---|---|
| 2025-12-31 | $1.50M 10-K · filed 2026-02-10 |
| 2024-12-31 | $1.50M 10-K · filed 2026-02-10 |
| 2023-12-31 | $1.50M 10-K · filed 2026-02-10 |
| 2022-12-31 | $1.30M 10-K · filed 2025-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |